Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT AND SERVICE TYPE LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET APPLICATION COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 MIDDLE EAST & AFRICA DIGITAL THERAPEUTICS (DTX) MARKET: REGULATIONS
5 MARKET OVERVIEW
5.1 DRIVERS
5.1.1 RISE IN PREVALENCE OF CHRONIC DISEASES
5.1.2 INCREASE IN AWARENESS BY GOVERNMENT AGENCIES
5.1.3 TECHNOLOGICAL ADVANCEMENT IN HEALTHCARE
5.1.4 INCREASED NUMBER OF PEOPLE USING SMARTPHONES
5.1.5 IMPROVED QUALITY OF LIFE
5.2 RESTRAINTS
5.2.1 PATIENT INFORMATION PRIVACY POLICIES
5.2.2 DIGITAL PAYMENT ASSOCIATED WITH DIGITAL THERAPEUTICS
5.2.3 UNDER DEVELOPING COUNTIRES LACKING SMARTPHONES AND INTERNET FACILITIES
5.3 OPPORTUNITIES
5.3.1 RISING DEMAND OF DIGITAL THERAPEUTICS
5.3.2 COLLABORATION BETWEEN COMPANIES TO PROVIDE BETTER PRODUCTS/SERVICES
5.3.3 PARTNERSHIP BETWEEN COMPANIES
5.3.4 EXPANSION AND LAUNCH OF PRODUCTS
5.3.5 EVENTS AND EXHIBITION
5.3.6 PHYSICIAN ADOPTION
5.4 CHALLENGES
5.4.1 CLINICAL VALIDATION
5.4.2 REGULATORY APPROVAL
5.4.3 PAYER REIMBURSEMENT
6 IMPACT OF COVID-19 ON MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET
6.1 IMPACT ON DEMAND
6.2 IMPACT ON SUPPLY
6.3 KEY INITIATIVES TAKEN BY PLAYERS DURING COVID-19
6.4 CONCLUSION
7 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE
7.1 OVERVIEW
7.2 SOLUTION/SOFTWARE
7.3 HARDWARE PRODUCTS
7.4 SERVICE
8 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION
8.1 OVERVIEW
8.2 TREATMENT/CARE-RELATED APPLIACTIONS
8.2.1 DIABETES
8.2.2 CENTRAL NERVOUS SYSTEM DISORDERS
8.2.3 SMOKING CESSATION
8.2.4 CHRONIC RESPIRATORY DISEASES
8.2.5 MUSCULOSKELETAL DISORDER
8.2.6 CARDIOVASCULAR DISEASES
8.2.7 MEDICATION ADHERENCE
8.2.8 GASTROINTESTINAL DISORDERS
8.2.9 REHABILITATION AND PATIENT CARE
8.2.10 SUBSTANCE USE DISORDER AND ADDICTION MANAGEMENT
8.2.11 OTHER TREATMENT/ CARE RELATED APPLICATIONS
8.3 PREVENTIVE APPLICATIONS
8.3.1 PREDIABETES
8.3.2 OBESITY
8.3.3 NUTRITION
8.3.4 LIFESTYLE MANAGEMENT
8.3.5 OTHER PREVENTIVE APPLICATIONS
9 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE
9.1 OVERVIEW
9.2 GROUP PURCHASE ORGANIZATION
9.2.1 SOLUTIONS/ SOFTWARE
9.2.2 HARDWARE PRODUCT
9.2.3 SERVICE
9.3 INDIVIDUAL
9.3.1 SOLUTIONS/ SOFTWARE
9.3.2 HARDWARE PRODUCT
9.3.3 SERVICE
10 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL
10.1 OVERVIEW
10.2 B2B
10.2.1 PAYERS
10.2.2 EMPLOYERS
10.2.3 PHARMA COMPANIES
10.2.4 PROVIDERS
10.2.5 OTHER BUYERS
10.3 B2C
10.3.1 CAREGIVERS
10.3.2 PATIENTS
11 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET, BY GEOGRAPHY
11.1 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET, BY COUNTRY
11.1.1 SAUDI ARABIA
11.1.2 SOUTH AFRICA
11.1.3 UAE
11.1.4 ISRAEL
11.1.5 EGYPT
11.1.6 REST OF MIDDLE EAST & AFRICA
12 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET: COMPANY LANDSCAPE
12.1 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA
13 SWOT
14 COMPANY PROFILE
14.1 FITBIT,INC.
14.1.1 COMPANY SNAPSHOT
14.1.2 REVENUE ANALYSIS
14.1.3 COMPANY SHARE ANALYSIS
14.1.4 PRODUCT PORTFOLIO
14.1.5 RECENT DEVELOPMENTS
14.2 LIVONGO
14.2.1 COMPANY SNAPSHOT
14.2.2 REVENUE ANALYSIS
14.2.3 COMPANY SHARE ANALYSIS
14.2.4 PRODUCT PORTFOLIO
14.2.5 RECENT DEVELOPMENTS
14.3 RESMED
14.3.1 COMPANY SNAPSHOT
14.3.2 REVENUE ANALYSIS
14.3.3 COMPANY SHARE ANALYSIS
14.3.4 PRODUCT PORTFOLIO
14.3.5 RECENT DEVELOPMENTS
14.4 OMADA HEALTH, INC.
14.4.1 COMPANY SNAPSHOT
14.4.2 COMPANY SHARE ANALYSIS
14.4.3 PRODUCT PORTFOLIO
14.4.4 RECENT DEVELOPMENTS
14.5 GINGER
14.5.1 COMPANY SNAPSHOT
14.5.2 PRODUCT PORTFOLIO
14.5.3 RECENT DEVELOPMENT
14.6 SAMSUNG
14.6.1 COMPANY SNAPSHOT
14.6.2 REVENUE ANALYSIS
14.6.3 PRODUCT PORTFOLIO
14.6.4 RECENT DEVELOPMENT
14.7 MINDSTRONG HEALTH
14.7.1 COMPANY SNAPSHOT
14.7.2 SERVICE PORTFOLIO
14.7.3 RECENT DEVELOPMENTS
14.8 2MORROW INC.
14.8.1 COMPANY SNAPSHOT
14.8.2 PRODUCT PORTFOLIO
14.8.3 RECENT DEVELOPMENTS
14.9 AKILI INTERACTIVE LABS, INC.
14.9.1 COMPANY SNAPSHOT
14.9.2 PRODUCT PORTFOLIO
14.9.3 RECENT DEVELOPMENTS
14.1 ATENTIV
14.10.1 COMPANY SNAPSHOT
14.10.2 PRODUCT PORTFOLIO
14.10.3 RECENT DEVELOPMENTS
14.11 AYOGO HEALTH INC.
14.11.1 COMPANY SNAPSHOT
14.11.2 PRODUCT PORTFOLIO
14.11.3 RECENT DEVELOPMENTS
14.12 BETTER THERAPEUTICS, INC
14.12.1 COMPANY SNAPSHOT
14.12.2 PRODUCT PORTFOLIO
14.12.3 RECENT DEVELOPMENTS
14.13 CANARY HEALTH
14.13.1 COMPANY SNAPSHOT
14.13.2 SOLUTION PORTFOLIO
14.13.3 RECENT DEVELOPMENT
14.14 CLICK THERAPEUTICS, INC.
14.14.1 COMPANY SNAPSHOT
14.14.2 PRODUCT PORTFOLIO
14.14.3 RECENT DEVELOPMENTS
14.15 COGNIFIT
14.15.1 COMPANY SNAPSHOT
14.15.2 PRODUCT PORTFOLIO
14.15.3 RECENT DEVELOPMENTS
14.16 COGNOA
14.16.1 COMPANY SNAPSHOT
14.16.2 PRODUCT PORTFOLIO
14.16.3 RECENT DEVELOPMENTS
14.17 GAIA AG
14.17.1 COMPANY SNAPSHOT
14.17.2 PRODUCT PORTFOLIO
14.17.3 RECENT DEVELOPMENTS
14.18 HAPPIFY, INC.
14.18.1 COMPANY SNAPSHOT
14.18.2 PRODUCT PORTFOLIO
14.18.3 RECENT DEVELOPMENTS
14.19 KAIA HEALTH
14.19.1 COMPANY SNAPSHOT
14.19.2 PRODUCT PORTFOLIO
14.19.3 RECENT DEVELOPMENTS
14.2 MANGO HEALTH
14.20.1 COMPANY SNAPSHOT
14.20.2 PRODUCT PORTFOLIO
14.20.3 RECENT DEVELOPMENTS
14.21 NATURAL CYCLES USA CORP
14.21.1 COMPANY SNAPSHOT
14.21.2 PRODUCT PORTFOLIO
14.21.3 RECENT DEVELOPMENT
14.22 NOOM, INC.
14.22.1 COMPANY SNAPSHOT
14.22.2 PRODUCT PORTFOLIO
14.22.3 RECENT DEVELOPMENT
14.23 PEAR THERAPEUTICS, INC.
14.23.1 COMPANY SNAPSHOT
14.23.2 PRODUCT PORTFOLIO
14.23.3 RECENT DEVELOPMENTS
14.24 SMARTPATIENT GMBH
14.24.1 COMPANY SNAPSHOT
14.24.2 PRODUCT PORTFOLIO
14.24.3 RECENT DEVELOPMENT
14.25 VOLUNTIS
14.25.1 COMPANY SNAPSHOT
14.25.2 REVENUE ANALYSIS
14.25.3 PRODUCT PORTFOLIO
14.25.4 RECENT DEVELOPMENTS
14.26 WELLDOC, INC.
14.26.1 COMPANY SNAPSHOT
14.26.2 PRODUCT PORTFOLIO
14.26.3 RECENT DEVELOPMENTS
14.27 WELLTHY THERAPEUTICS PVT LTD
14.27.1 COMPANY SNAPSHOT
14.27.2 PRODUCT PORTFOLIO
14.27.3 RECENT DEVELOPMENTS
15 QUESTIONNAIRE
16 RELATED REPORTS
List of Table
LIST OF TABLES
TABLE 1 REGULATORY FRAMEWORK
TABLE 2 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE, 2020-2028 (USD MILLION)
TABLE 3 MIDDLE EAST & AFRICA SOLUTIONS/SOFTWARE IN DIGITAL THERAPEUTIC (DTX) MARKET, BY REGION, 2019-2028 (USD MILLION))
TABLE 4 MIDDLE EAST & AFRICA HARDWARE PRODUCTS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 5 MIDDLE EAST & AFRICA SERVICE IN DIGITAL THERAPEUTIC (DTX) MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 6 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2020-2028 (USD MILLION)
TABLE 7 MIDDLE EAST & AFRICA TREATMENT/CARE-RELATED APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 8 MIDDLE EAST & AFRICA TREATMENT/CARE-RELATED APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 9 MIDDLE EAST & AFRICA PREVENTIVE APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 10 MIDDLE EAST & AFRICA PREVENTIVE APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 11 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2020-2028 (USD MILLION)
TABLE 12 MIDDLE EAST & AFRICA GROUP PURCHASE ORGANIZATION IN DIGITAL THERAPEUTIC (DTX) MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 13 MIDDLE EAST & AFRICA GROUP PURCHASE ORGANIZATION IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)
TABLE 14 MIDDLE EAST & AFRICA INDIVIDUAL IN DIGITAL THERAPEUTIC (DTX) MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 15 MIDDLE EAST & AFRICA INDIVIDUAL IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)
TABLE 16 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2020-2028 (USD MILLION)
TABLE 17 MIDDLE EAST & AFRICA B2B IN DIGITAL THERAPEUTIC (DTX) MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 18 MIDDLE EAST & AFRICA B2B IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)
TABLE 19 MIDDLE EAST & AFRICA B2C IN DIGITAL THERAPEUTIC (DTX) MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 20 MIDDLE EAST & AFRICA B2C IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)
TABLE 21 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET, BY COUNTRY, 2019-2028 (USD MILLION)
TABLE 22 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 23 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 24 MIDDLE EAST & AFRICA TREATMENT/CARE-RELATED APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 25 MIDDLE EAST & AFRICA PREVENTIVE APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 26 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)
TABLE 27 MIDDLE EAST & AFRICA GROUP PURCHASE ORGANIZATION IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)
TABLE 28 MIDDLE EAST & AFRICA INDIVIDUAL IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)
TABLE 29 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)
TABLE 30 MIDDLE EAST & AFRICA B2B IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)
TABLE 31 MIDDLE EAST & AFRICA B2C IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)
TABLE 32 SAUDI ARABIA DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 33 SAUDI ARABIA DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 34 SAUDI ARABIA TREATMENT/CARE-RELATED APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 35 SAUDI ARABIA PREVENTIVE APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 36 SAUDI ARABIA DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)
TABLE 37 SAUDI ARABIA GROUP PURCHASE ORGANIZATION IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)
TABLE 38 SAUDI ARABIA INDIVIDUAL IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)
TABLE 39 SAUDI ARABIA DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)
TABLE 40 SAUDI ARABIA B2B IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)
TABLE 41 SAUDI ARABIA B2C IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)
TABLE 42 SOUTH AFRICA DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 43 SOUTH AFRICA DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 44 SOUTH AFRICA TREATMENT/CARE-RELATED APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 45 SOUTH AFRICA PREVENTIVE APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 46 SOUTH AFRICA DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)
TABLE 47 SOUTH AFRICA GROUP PURCHASE ORGANIZATION IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)
TABLE 48 SOUTH AFRICA INDIVIDUAL IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)
TABLE 49 SOUTH AFRICA DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)
TABLE 50 SOUTH AFRICA B2B IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)
TABLE 51 SOUTH AFRICA B2C IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)
TABLE 52 UAE DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 53 UAE DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 54 UAE TREATMENT/CARE-RELATED APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 55 UAE PREVENTIVE APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 56 UAE DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)
TABLE 57 UAE GROUP PURCHASE ORGANIZATION IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)
TABLE 58 UAE INDIVIDUAL IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)
TABLE 59 UAE DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)
TABLE 60 UAE B2B IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)
TABLE 61 UAE B2C IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)
TABLE 62 ISRAEL DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 63 ISRAEL DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 64 ISRAEL TREATMENT/CARE-RELATED APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 65 ISRAEL PREVENTIVE APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 66 ISRAEL DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)
TABLE 67 ISRAEL GROUP PURCHASE ORGANIZATION IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)
TABLE 68 ISRAEL INDIVIDUAL IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)
TABLE 69 ISRAEL DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)
TABLE 70 ISRAEL B2B IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)
TABLE 71 ISRAEL B2C IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)
TABLE 72 EGYPT DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE, 2019-2028 (USD MILLION)
TABLE 73 EGYPT DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 74 EGYPT TREATMENT/CARE-RELATED APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 75 EGYPT PREVENTIVE APPLICATIONS IN DIGITAL THERAPEUTIC (DTX) MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 76 EGYPT DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)
TABLE 77 EGYPT GROUP PURCHASE ORGANIZATION IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)
TABLE 78 EGYPT INDIVIDUAL IN DIGITAL THERAPEUTIC (DTX) MARKET, BY PURCHASE MODE, 2019-2028 (USD MILLION)
TABLE 79 EGYPT DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)
TABLE 80 EGYPT B2B IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)
TABLE 81 EGYPT B2C IN DIGITAL THERAPEUTIC (DTX) MARKET, BY SALES CHANNEL, 2019-2028 (USD MILLION)
TABLE 82 REST OF MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET, BY PRODUCT AND SERVICE TYPE, 2019-2028 (USD MILLION)
List of Figure
LIST OF FIGURES
FIGURE 1 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET: SEGMENTATION
FIGURE 2 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET : DATA TRIANGULATION
FIGURE 3 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET: DROC ANALYSIS
FIGURE 4 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET: MIDDLE EAST & AFRICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET: MULTIVARIATE MODELLING
FIGURE 7 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 8 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET: DBMR MARKET POSITION GRID
FIGURE 9 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 10 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET: VENDOR SHARE ANALYSIS
FIGURE 11 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET: SEGMENTATION
FIGURE 12 INCREASING DEMAND OF DIGITAL THERAPEUTICS WORLDWIDE DUE TO PREVALENCE OF CHRONIC DISEASES IS EXPECTED TO DRIVE THE MARKET GROWTH IN THE FORECAST PERIOD OF 2021 TO 2028.
FIGURE 13 SOLUTIONS/SOFTWARE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET IN 2021 & 2028
FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET
FIGURE 15 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET: BY PRODUCT AND SERVICE TYPE, 2020
FIGURE 16 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET: BY PRODUCT AND SERVICE TYPE, 2020-2028 (USD MILLION)
FIGURE 17 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET: BY PRODUCT AND SERVICE TYPE, CAGR (2021-2028)
FIGURE 18 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET: BY PRODUCT AND SERVICE TYPE, LIFELINE CURVE
FIGURE 19 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET: BY APPLICATION, 2020
FIGURE 20 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET: BY APPLICATION, 2020-2028 (USD MILLION)
FIGURE 21 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET: BY APPLICATION, CAGR (2021-2028)
FIGURE 22 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 23 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET: BY PURCHASE MODE, 2020
FIGURE 24 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET: BY PURCHASE MODE, 2020-2028 (USD MILLION)
FIGURE 25 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET: BY PURCHASE MODE, CAGR (2021-2028)
FIGURE 26 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET: BY PURCHASE MODE, LIFELINE CURVE
FIGURE 27 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET: BY SALES CHANNEL, 2020
FIGURE 28 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET: BY SALES CHANNEL, 2020-2028 (USD MILLION)
FIGURE 29 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET: BY SALES CHANNEL, CAGR (2021-2028)
FIGURE 30 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET: BY SALES CHANNEL, LIFELINE CURVE
FIGURE 31 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET: SNAPSHOT (2020)
FIGURE 32 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET: BY COUNTRY (2020)
FIGURE 33 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET: BY COUNTRY (2021 & 2028)
FIGURE 34 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET: BY COUNTRY (2020 & 2028)
FIGURE 35 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET: BY PRODUCT AND SERVICE (2021-2028)
FIGURE 36 MIDDLE EAST & AFRICA DIGITAL THERAPEUTIC (DTX) MARKET: COMPANY SHARE 2020 (%)
